The Trump administration finalized a regulation Thursday that cuts the Medicare reimbursement for new cancer and other specialty drugs, which administration officials say could lower costs for seniors.
The administration released on Thursday final regulations for doctor reimbursements under Medicare for 2019, including a proposal to cut payment amounts for new drugs covered under Medicare Part B, which reimburses doctors and hospitals for drugs administered in offices or facilities.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.